Biotech Sector Outlook Navigating the Next Phase VIV Q1 2026 Earnings EPS Miss Exceeds 23 Amid Challenging Operating Environment US Stock Futures and Bond Yields Decline on Reports of Updated Russian Nuclear Doctrine